Can prophylactic breast irradiation contribute to cardiac toxicity in patients with prostate cancer receiving androgen suppressing drugs?

BACKGROUND: Androgen suppression treatment (AST) might increase the risk of cardiac morbidity in prostate cancer patients. Possible explanations were provided, however, they disregard the potential contribution of prophylactic radiotherapy to the mamillary regions (PMRT, prescribed to avoid gynecoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Nieder, Carsten, Pawinski, Adam, Andratschke, Nicolaus H, Molls, Michael
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2249590/
https://www.ncbi.nlm.nih.gov/pubmed/18186924
http://dx.doi.org/10.1186/1748-717X-3-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2249590/
https://www.ncbi.nlm.nih.gov/pubmed/18186924
http://dx.doi.org/10.1186/1748-717X-3-2

Ejemplares similares